Format

Send to

Choose Destination
Breast. 2015 Nov;24 Suppl 2:S15-8. doi: 10.1016/j.breast.2015.07.005.

Big data: Are large prospective randomized trials obsolete in the future?

Author information

1
Memorial Sloan Kettering Cancer Center, United States; Weill Cornell Medical College, United States. Electronic address: hudisc@mskcc.org.

Abstract

Big data represents a new opportunity to increase our understanding of cancer care as it is practiced globally and to improve it through the refinement of clinic guidelines and the identification of knowledge gaps. Here we review the historical approach to evidence development (randomized clinical trials), some of their limitations, and the complementary role that big data analytics may play.

KEYWORDS:

Big data; Cancer; Clinical trials

PMID:
26255742
DOI:
10.1016/j.breast.2015.07.005
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center